Prasad R. Koduru

Medical Genetics
6000 Harry Hines Blvd
Dallas, TX 75235

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications

Clonally Related Chronic Lymphocytic Leukemia and Malignant Histiocytic Neoplasm (Histiocytic Sarcoma With Overlapping Langerhans Cell Phenotype): Divergent Evolution From a Shared Cell-Of-Origin.

Clonally Related Chronic Lymphocytic Leukemia and Malignant Histiocytic Neoplasm (Histiocytic Sarcoma With Overlapping Langerhans Cell Phenotype): Divergent Evolution From a Shared Cell-Of-Origin.

Journal: American journal of hematology
Published: August 24, 2026

Deletion 11q, monosomy 13, and deletion 13q in noncomplex karyotype acute myeloid leukemia.

Deletion 11q, monosomy 13, and deletion 13q in noncomplex karyotype acute myeloid leukemia.

Journal: Blood neoplasia
Published: March 24, 2026

Cytogenetic and Molecular Analysis of a "Double-Hit" RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid Leukemia.

Cytogenetic and Molecular Analysis of a "Double-Hit" RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid Leukemia.

Journal: Genes, chromosomes & cancer
Published: February 18, 2026

Correlation of NPM1 immunohistochemistry with mutation subtypes, clinicopathologic variables and molecular testing in AML with NPM1 mutation.

Correlation of NPM1 immunohistochemistry with mutation subtypes, clinicopathologic variables and molecular testing in AML with NPM1 mutation.

Journal: Human pathology
Published: November 12, 2025

EWSR1-and FUS-rearranged acute leukemias: Clinicopathological and genomic characterization.

EWSR1-and FUS-rearranged acute leukemias: Clinicopathological and genomic characterization.

Journal: Human pathology
Published: September 14, 2025

Clonal cytogenetic abnormality in IgG4-related disease.

Clonal cytogenetic abnormality in IgG4-related disease.

Journal: Cancer genetics
Published: August 12, 2025

B/T mixed phenotype acute leukemia revealing immunophenotypic lineage-genotype associations and frequent myelodysplasia-related cytogenetic/gene abnormalities: implication for diagnosis and treatment.

B/T mixed phenotype acute leukemia revealing immunophenotypic lineage-genotype associations and frequent myelodysplasia-related cytogenetic/gene abnormalities: implication for diagnosis and treatment.

Journal: Annals of diagnostic pathology
Published: July 04, 2025

Distinct structural and numerical chromosome abnormalities determine the MYC status in diffuse large B-Cell lymphoma and help differentiate from Burkitt lymphoma: a cytogenetic data analysis using unsupervised and AI-driven prediction models.

Distinct structural and numerical chromosome abnormalities determine the MYC status in diffuse large B-Cell lymphoma and help differentiate from Burkitt lymphoma: a cytogenetic data analysis using unsupervised and AI-driven prediction models.

Journal: Annals of hematology
Published: May 27, 2025

Imatinib-Induced Clinical Response in ETV6::ACSL6 Myeloid Neoplasm with Eosinophilic Pneumonitis: A Case Report.

Imatinib-Induced Clinical Response in ETV6::ACSL6 Myeloid Neoplasm with Eosinophilic Pneumonitis: A Case Report.

Journal: The American journal of case reports
Published: April 09, 2025

Trisomy 8 in De Novo Acute Myeloid Leukemia Lacking MDS-Related Cytogenetics Does Not Significantly Influence Survival.

Trisomy 8 in De Novo Acute Myeloid Leukemia Lacking MDS-Related Cytogenetics Does Not Significantly Influence Survival.

Journal: International journal of laboratory hematology
Published: January 22, 2025

Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment.

Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment.

Journal: European journal of haematology
Published: January 11, 2025

A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis.

A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis.

Journal: The Journal of clinical investigation
Published: January 07, 2025
Showing 1-12 of 84

Last Updated: 09/26/2026